dexrazoxane has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brion, A; Cahn, JY; Daguindau, E; Deconinck, E; Limat, S; Nerich, V; Perrin, S; Woronoff-Lemsi, MC | 1 |
1 other study(ies) available for dexrazoxane and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cardiotonic Agents; Cyclophosphamide; Dexrazoxane; Doxorubicin; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prednisone; Retrospective Studies; Risk Factors; Rituximab; Vincristine; Young Adult | 2014 |